Rosemina Merchant
Fondateur chez MEDICENNA THERAPEUTICS CORP.
Fortune : 7 M $ au 30/04/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Fahar Merchant | M | - |
Intelligene Expressions, Inc.
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | 29 ans |
Jack Geltosky | M | 78 | 16 ans | |
Albert Beraldo | M | - |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | 8 ans |
Andrew L. Strong | M | 57 |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | 5 ans |
Karen Dawes | F | 72 | 5 ans | |
Delphine Davan | F | - | 1 ans | |
John Sampson | M | - | 3 ans | |
Eamonn Peters | M | - | 1 ans | |
David Hyman | M | - | - | |
Evelyn Pau | M | - | 1 ans | |
Minh To | M | - | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Elizabeth Williams | F | - | 7 ans | |
Randall E. Woods | M | 72 | - | |
Chandrakant Panchal | M | 74 |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | 7 ans |
Lars Ekman | M | 74 | 10 ans | |
Frank Holler | M | 67 | 9 ans | |
Allison Hulme | M | 61 | - | |
Leonard J. Cox | M | 52 | 2 ans | |
Amit Sobti | M | 45 | 2 ans | |
Peter Slover | M | 49 | - | |
William R. Rohn | M | 80 | 3 ans | |
Nishan de Silva | M | 51 | 2 ans | |
William Li | M | 61 | 2 ans | |
David Swetlow | M | - | 2 ans | |
Jonathan Leff | M | 55 | 2 ans | |
Samuel R. Denmeade | M | - | - | |
Mark R. Brunswick | M | - | 5 ans | |
Jay Stoudemire | M | - | - | |
Humphrey Gardner | M | 60 | 1 ans | |
Annica Mårtensson | M | - | - | |
Patrick Ward | M | - | - | |
Martin Bexon | M | - | - | |
Mann Muhsin | M | - | 1 ans | |
Brent Meadows | M | - | - | |
John Parkinson | M | - | - | |
Richard C. Yocum | M | 68 | 5 ans | |
Kenneth H. Haas | M | 73 |
Intelligenetics, Inc.
Intelligenetics, Inc. Information Technology ServicesTechnology Services Intelligenetics, Inc. engages in the provision of bioinformatics services. The company is headquartered in Campbell, CA. | 9 ans |
Thomas D'Orazio | M | - | - | |
Shafique Fidai | M | - | - | |
Kevin Moulder | M | - | 1 ans | |
Anthony Boone | M | - | - | |
Jim J. Miller | M | 64 | 5 ans | |
Kevin McDuffie | M | - | - | |
Alexander R. Giaquinto | M | 80 | 1 ans | |
Trevor Wong-Chor | M | 56 | - | |
Nitin Kaushal | M | 58 | 5 ans | |
Noah Knauf | M | 44 | 1 ans | |
Avtar Dhillon | M | 62 | 7 ans | |
Alexander Casdin | M | 56 | 1 ans | |
Don B. Rix | M | 93 | 5 ans | |
Jeff Caravella | M | - | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Canada | 50 | 98,04% |
Etats-Unis | 1 | 1,96% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Rosemina Merchant
- Réseau Personnel